跳至主要内容
临床试验/ACTRN12605000060640
ACTRN12605000060640已完成4 期

A single centre double blinded randomised controlled trial of adjunctive granulocyte â¿¿ colony stimulating factor in septic shock (excluding melioidosis) to determine affects on morbidity and mortality.

Intensive care unit, Royal Darwin Hospital0 个研究点目标入组 164 人开始时间: 2005年8月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
164

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • Participants must fit the ACCP/SCCM Consensus Criteria for septic shock and other more recently agreed-upon non-invasive criteria. These criteria are; at least 2 signs of the presence of infection, cardiovascular failure (shock) and at least 1 sign of organ perfusion abnormality.

排除标准

  • Culture confirmed melioidosis, febrile neutropaenia (following chemotherapy), known haematological malignancy, myelodysplasia or congenital neutropaenia, pregnancy, known hypersensitivity to G-CSF, known objection to participate in the trial, previous transplantation, previous participation in this trial, has received G-CSF in the past month, brain death, expected survival of less than 24 hours with active orders limiting treatment and myocardial infarction in the previous 24 hours.

研究者

发起方
Intensive care unit, Royal Darwin Hospital

相似试验